LogicBio Therapeutics to Participate in Upcoming Investor Conferences
- Barclays Gene Editing & Gene Therapy Summit: Fireside chat at
8:00 a.m. ET onMonday, November 15, 2021 Jefferies Virtual London Healthcare Conference : Pre-recorded corporate presentation will be available beginning at3:00 a.m. ET onThursday, November 18, 2021
A live webcast of the Barclays Gene Editing & Gene Therapy Summit fireside chat and a webcast replay of the Jefferies London presentation will be made available on the Investors section of the Company's website at https://investor.logicbio.com. The webcasts will be available for approximately 30 days.
About LogicBio Therapeutics
LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering genome editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood. The company's genome editing platform, GeneRide™, is a new approach to precise gene insertion harnessing a cell's natural DNA repair process potentially leading to durable therapeutic protein expression levels. The company's gene delivery platform, sAAVy™, is an adeno-associated virus (AAV) capsid engineering platform designed to optimize gene delivery for treatments in a broad range of indications and tissues. The company is based in Lexington, MA. For more information, visit www.logicbio.com, which does not form a part of this release.
Investor Contacts:
(619) 916-7620
laurence@gilmartinir.com
(858) 525-2047
stephen@gilmartinir.com
Media Contacts:
Berry & Company Public Relations
W:212-253-8881
C: 614-580-2048
adaley@berrypr.com
View original content:https://www.prnewswire.com/news-releases/logicbio-therapeutics-to-participate-in-upcoming-investor-conferences-301422553.html
SOURCE